期刊文献+

碳酸锂联合奥氮平对双相躁狂患者外周血单核细胞糖原合成酶激酶3活性的影响 被引量:4

The impact of treatment of lithium and olanzapine on glycogen synthase kinase-3 activity in the peripheral blood mononuclear cells of patients with bipolar mania
下载PDF
导出
摘要 目的:探讨碳酸锂联合奥氮平治疗对双相躁狂发作患者外周血单核细胞(PBMCs)糖原合成酶激酶3(GSK3)活性的影响。方法:21例双相I型躁狂发作患者给予碳酸锂合并奥氮平治疗8周,于治疗前、治疗4周和8周采集患者外周静脉血20ml,应用免疫印迹法检测PBMCs的GSK3α和GSK3β丝氨酸磷酸化水平以及总GSK3水平。同时采用杨氏躁狂量表(YMRS)、蒙哥马利抑郁量表(MADRS)以及临床疗效总评量表-病情严重程度(CGI-S)评定症状变化。结果:①治疗后YMRS、MADRS以及CGI-S评分较治疗前明显降低(P均<0.001);②治疗后PBMCs的pSer-GSK3α、pSer-GSK3β较治疗前升高,以pSer-GSK3β尤为明显,由治疗前的(53.44±17.57)%升高至治疗8周的(72.96±25.66)%。剔除躁狂发作次数≥3次者后比较,治疗8周pSer-GSK3β升高更为显著(P=0.022);③pSer9-GSK3β/to-tal-GSK3β比值与YMRS基线评分呈负相关(r=-0.-487,P=0.025)。结论:碳酸锂合并奥氮平治疗可以升高双相躁狂患者PBMCs的GSK3β磷酸化水平,降低GSK3活性。 Objective:To explore the impact of treatment of lithium and olanzapine on glycogen synthase kinase-3(GSK3) activity in the peripheral blood mononuclear cells(PBMCs) of patients with bipolar mania. Method:21 patients with bipolar I mania were enrolled and received treatment of lithium and olanzapine for eight weeks.20 ml of blood was collected from each patient by venipuncture at week 0,week 4 and week 8.The level of pSer21-GSK3α,pSer9-GSK3β,total GSK3α and GSK3β in PBMCs of patients were measured by western blot when blood samples of three visits were collected.Clinical symptoms were assessed with the Young mania rating scale(YMRS) ,the Montgomery-Asberg depression rating scale(MADRS) and the clinical global impression for bipolar disorder-severity(CGI-S) at the same time. Results:①The average scores of YMRS,MADRS,and CGI-S significantly reduced at week 8 compared with those at week 0(P0.001);②The level of pSer-GSK3α and pSer-GSK3β increased at week 8.The increase was especially apparent in pSer-GSK3β from(53.44±17.57) at week 0 to(72.96±25.66) at week 8;Excluding patients with manic episodes more than 3 times,there is a significant increase in pSer-GSK3β during the eight-week treatment(P=0.022);③There was a negative correlation between ratio of pSer-GSK3β to total-GSK3β and the average score of YMRS at week 0(r= -0.-487,P=0.025) . Conclusion:Lithium and olanzapine could increase the level of pSer-GSK3β in PBMCs of patients with bipolar mania and decrease GSK3 activity.
出处 《临床精神医学杂志》 2011年第6期415-419,共5页 Journal of Clinical Psychiatry
关键词 双相障碍躁狂发作 碳酸锂 奥氮平 糖原合成酶激酶3 bipolar mania lithium olanzapine glycogen synthase kinase 3
  • 相关文献

参考文献13

  • 1Jope RS, Roh MS. Glycogen synthase kinase-3 ( GSK3 ) in psychiatric diseases and therapeutic interventions [ J ]. Curr Drug Targets, 2006,7 : 1421-1434. 被引量:1
  • 2Prickaerts J, Moechars D, Cryns K, et al. Transgenic mice overexpressing glycogen synthase kinase 3β: a putative model of hyperactivity and mania[ J]. J Neurosci ,2006,26:9022-9029. 被引量:1
  • 3Pandey GN, Ren X, Rizavi HS, et al. Glycogen synthase kinase-3beta in the platelets of patients with mood disorders: effect of treatment [ J ]. J Psychiatr Res ,2010,44 : 143-148. 被引量:1
  • 4De Samo P, Li X, Jope RS. Regulation of akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium [J]. Neuropharmaeology,2002,43 : 1158-1164. 被引量:1
  • 5Li X, Rosborough KM, Friedman AB, et al. Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics [ J ]. J Neuropsychopharmaeol,2007 ,10 :7-19. 被引量:1
  • 6Li X, Friedman AB, Zhu W, et al. Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder [ J ]. Biol Psychiatry ,2007,61:216-222. 被引量:1
  • 7金冬雁,黎孟枫,译.分子克隆实验指南[M].2版北京:科学出版社,1998:399,448. 被引量:6
  • 8Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein dye binding[ J]. Analytical Biochem, 1976,72:248-254. 被引量:1
  • 9Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3β in cellular signaling[ J]. Prog Neurobiol, 2001,65 : 391 - 426. 被引量:1
  • 10Jope RS, Johnson GV. The glamour and gloom of glycogen synthase kinase-3 [J]. Trends Biochem Sci,2004,29:95-102. 被引量:1

共引文献5

同被引文献30

  • 1J·萨姆布鲁克,E·F·弗里奇,T·曼尼阿蒂斯著.金冬雁,黎孟枫译.分子克隆实验指南[M].2版.北京:科学出版社,1992:464-467. 被引量:2
  • 2Jope R S,Roh M S.Glycogen synthase kinase-3(GSK3)in psychiatric diseases and therapeutic interventions[J].Curr Drug Targets,2006,7(11):1421-1434. 被引量:1
  • 3Prickaerts J,Moechars D,Cryns K,et al.Transgenic mice overexpressing glycogen synthase kinase 3β:a putative model of hyperactivity and mania[J].J Neurosci,2006,26(35):9022-9029. 被引量:1
  • 4American Psychiatric Association.Diagnostic and statistic manual of mental disorders[M].Washington,DC:American Psychiatric Press,Inc.,2000. 被引量:1
  • 5Bradford M M.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding[J].Anal Biochem,1976,72:248-254. 被引量:1
  • 6Grimes C A,Jope R S.The multifaceted roles of glycogen synthase kinase 3βin cellular signaling[J].Prog Neurobiol,2001,65(4):391-426. 被引量:1
  • 7Jope R S,Johnson G V.The glamour and gloom of glycogen synthase kinase-3[J].Trends Biochem Sci,2004,29(2):95-102. 被引量:1
  • 8Mai L,Jope R S,Li X.BDNF-mediated signal transduction is modulated by GSK3 and mood stabilizing agents[J].J Neurochem,2002,82(1):75-83. 被引量:1
  • 9De Sarno P,Li X,Jope R S.Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium[J].Neuropharmacology,2002,43(7):1158-1164. 被引量:1
  • 10Stambolic V,Ruel L,Woodgett J R.Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells[J].Curr Biol,1996,6(12):1664-1668. 被引量:1

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部